学术探索
学术期刊
新闻热点
数据分析
智能评审

Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies

被引：40
作者：
Calvert, AH [1 ]
Egorin, MJ [1 ]
机构：
[1] Univ Newcastle, Sch Med, Dept Oncol, Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷 / 01期
关键词：
D O I：
10.1016/S0959-8049(01)00340-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：11 / 16
页数：6
相关论文
共 52 条
  • [31] RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND TUMOR RESPONSE AND TOXICITY IN PATIENTS WITH OVARIAN-CANCER
    JODRELL, DI
    EGORIN, MJ
    CANETTA, RM
    LANGENBERG, P
    GOLDBLOOM, EP
    BURROUGHS, JN
    GOODLOW, JL
    TAN, S
    WILTSHAW, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 520 - 528
  • [32] Johnsson A, 1998, CANCER CHEMOTH PHARM, V41, P248
  • [33] Korst AEC, 1997, CLIN CANCER RES, V3, P697
  • [34] Calvert's formula for dosing carboplatin: Overview and concerns of applicability in high-dose setting
    Mazumdar, M
    Smith, A
    Tong, WP
    Motzer, RJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (17) : 1434 - 1436
  • [35] Miyazaki M, 1997, ANTICANCER RES, V17, P4571
  • [36] CARBOPLATIN PHARMACOKINETICS IN CHILDREN - THE DEVELOPMENT OF A PEDIATRIC DOSING FORMULA
    NEWELL, DR
    PEARSON, ADJ
    BALMANNO, K
    PRICE, L
    WYLLIE, RA
    KEIR, M
    CALVERT, AH
    LEWIS, IJ
    PINKERTON, CR
    STEVENS, MCG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) : 2314 - 2323
  • [37] Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae
    Okamoto, H
    Nagatomo, A
    Kunitoh, H
    Kunikane, H
    Watanabe, K
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (04) : 307 - 312
  • [38] A limited-sampling model for the pharmacokinetics of carboplatin administered in combination with paclitaxel
    Panday, VRN
    van Warmerdam, LJC
    Huizing, MT
    Huinink, WWT
    Schellens, JHM
    Beijnen, JH
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (11) : 615 - 620
  • [39] IMPACT OF CYCLOPHOSPHAMIDE ON RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND RESPONSE OR TOXICITY WHEN USED IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
    REYNO, LM
    EGORIN, MJ
    CANETTA, RM
    JODRELL, DI
    SWENERTON, KD
    PATER, JL
    BURROUGHS, JN
    NOVAK, MJ
    SRIDHARA, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) : 1156 - 1164
  • [40] A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
    Sculier, JP
    Paesmans, M
    Thiriaux, J
    Lecomte, J
    Bureau, G
    Giner, V
    Koumakis, G
    Lafitte, JJ
    Berchier, MC
    Alexopoulos, CG
    Zacharias, C
    Mommen, P
    Ninane, V
    Klastersky, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (09) : 1314 - 1319
123456